# Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia

> **NCT00481624** · PHASE2 · WITHDRAWN · sponsor: **University of Louisville**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin Alfa plus Iron

## Key facts

- **NCT ID:** NCT00481624
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was stopped because of lack of funding.
- **Last updated:** 2018-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481624, "Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00481624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*